Stocktoria
ICON PLC ICLR
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 1998-05-15
ICON PLC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 5.4% | 12.6% | 11.2% | 10.3% | 6.9% |
| Net margin | 2.8% | 9.0% | 6.9% | 6.5% | 2.8% |
| FCF margin | 10.4% | 13.7% | 12.7% | 5.4% | 13.4% |
| Return on assets | 1.4% | 4.4% | 3.3% | 2.9% | 0.9% |
| Return on equity | 2.5% | 7.8% | 6.0% | 5.9% | 1.9% |
| Debt / equity | 0.31× | 0.36× | 0.41× | 0.55× | 0.68× |
| Current ratio | 1.10 | 1.24 | 1.20 | 1.20 | 1.19 |
| Revenue growth | 0.8% | 1.7% | 4.1% | 41.2% | 95.9% |
Source: SEC EDGAR filings · CIK 0001060955 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.